Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Prof Amant presents results from an ongoing, observational, case-control study at an ECC 2015 press conference revealing that women who are diagnosed with cancer during their pregnancy can start treatment immediately.
The study findings, published in the New England Journal of Medicine (doi: 10.1056/NEJMoa1508913), also show that women do not need to terminate their pregnancy because of worries about the effects of cancer therapy on the development of their child.
Read the news story or watch the video interview for more.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
Choosing Wisely in endometrial & cervix cancers: Medical therapy
Psychological issues in familial cancer
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Ponatinib is better than imatinib for frontline treatment of newly diagnosed Ph+ acute lymphoblastic leukaemia
Special Issue on paediatric oncology